Reply  by Yoshino, Masanori et al.
LETTERS TO THE EDITOR
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1Regarding “Mandibular subluxation stabilized by
mouthpiece for distal internal carotid artery exposure
in carotid endarterectomy”
We read with interest the report by Yoshino et al1 of their
technique for achieving mandibular subluxation for distal internal
carotid artery (ICA) exposure. The indications for extended carotid
exposure are well established, and mandibular subluxation is a mini-
mally invasive procedure to gain 15 to 20 mm additional exposure of
the ICA. The authors advocate the use of a custom-made resin
mouthpiece. The possible advantages of this method would be re-
duced oral injury and infection, avoidance of dislocation of the tem-
poromandibular joint (TMJ) and short preparation time.We recently
reported in the Journal of Vascular Surgery on the use of ipsilateral
monocorticalminiscrews andwiring for this indication2with the same
advantages as stated in their article.Wedonot recognize thedescribed
injury and infection to the oral cavity in our routine. These complica-
tions are extremely rare due to the excellent blood support to the
alveolar ridge and theminimally invasive nature ofminiscrews.Only in
cases of an extremely resorbed mandibula could wound healing dis-
turbances theoretically occur.
Second, there is the issue of the practical applicability and
stability of the described resin mouthpiece. It was possible to
produce a mouthpiece in 57% of the described patients. In our
population, this amount would be even lower due to periodontal
disease and absence of dentition. Next to the issue of the presence
of an adequate dentition, it would be interesting if the authors
describe whether the resin mouthpiece has enough stability and
retention on the existing dentition to withstand the muscular
retraction forces during operation, which can reduce the amount
of subluxation and subsequently the exposure of the ICA.
A third possible disadvantage of this technique is the thickness
of the mouthpiece. Interposition of resin material between the
dental arches causes opening of the bite and movement of the
mandibular angle in a backward direction over the desired exposed
area of the ICA. Therefore, we feel it should be desired to produce
a position of maximum flexion in the TMJ. The suggestion that the
production of amouthpiece ofmandibular subluxation in an awake
situation will produce fewer disturbances to the TMJ than per-
forming this in general anesthesia is unsubstantiated. In our expe-
rience, mandibular subluxation without dislocation of the TMJ can
easily be achieved in the experienced hands of a dentist or maxill-
ofacial surgeon. We have not had the experience that patients
suffered from postoperative TMJ complaints. We do see that the
extension of the subluxation under general anesthesia is greater
that in an awake patient, which gives a better exposure of the ICA.
In summary, the suggested benefits of a resin mouthpiece over
the use of monocortical screws may be questioned. It is more
expensive, time-consuming in preparation, and, in our opinion,
not as reliable as using monocortical miniscrews and wiring.
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We thank Dr Jaspers et al for their interest in our article1 and
re happy to reply to their comments:
irst, although their technique provides the same advantages as our
technique for exposure of the operative field, we think that the
technique carries potential risks, such as bleeding, infection,
and dental injury, because the insertion of screws is an invasive
procedure. They report no such complications, but in only
four cases.2 Even if such complications are extremely rare, it is
better to avoid invasive procedures.
econd, it is true that our technique cannot be used for edentulous
patients, and this is an important disadvantage. In our experi-
ence, the mouthpiece provides adequate stability, has never
fallen back during surgery, and has never interfered with the
operative field.
hird, our illustrations exaggerate the resin material between the
dental arches for easier interpretation, but as shown in our
photographs, the thickness of the resin is only about 2 mm.
Therefore, the displacement of the mandibular angle in the
backward direction is very small and has a very small effect
during the operation.
We know that extension of the subluxation under general
nesthesia is greater than that in an awake patient, but in our
xperience, the exposure of the internal carotid artery is rarely
ifferent between these conditions. Therefore, we recommend
ur technique because it is less likely to cause dislocation of the
emporomandibular joint. It is possible that an experienced
entist or maxillofacial surgeon can achieve adequate mandib-
lar subluxation without dislocation, but not all dentists and
axillofacial surgeons have the requisite skills or experience.
his type of mouthpiece is commonly used for the treatment of
emporomandibular disorders, so any dentist ought to be able
o perform our technique with the information included in this
rticle.
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Regarding “Infrapopliteal balloon angioplasty for the
treatment of chronic occlusive disease”
Critical limb ischemia (CLI) usually represents extensive multi-
level arterial occlusive disease, often requiring infrapopliteal revascu-
larization. Angioplasty also seems very promising in this segment.
Previous studies on the effect of infrapopliteal angioplasty inCLIwere
often limited by a lack of description of patient and lesion character-
istics. In a recent article in the Journal of Vascular Surgery,Conrad et
al1 described their results with infrapopliteal angioplasty in a large
study with 144 patients and with well-described CLI and lesion
characteristics. The limb salvage rate at 40 months of follow-up
was 86%, despite inferior patency rates. The authors concluded
that infrapopliteal angioplasty should be considered the initial
therapy for these patients.
Important information is missing in their report, however.
Almost 70% of their patients had diabetes mellitus, and claiming a
success in limb salvage as a result of angioplasty in such patients
seems somehow inappropriate. Tissue loss and healing of ulcers in
diabetic patients is strongly related to diabetic neuropathy, infec-
tions, and microvascular diabetic complications, besides peripheral
arterial occlusive disease.2 Many of these patients often have an
ankle-brachial index of about 50 mm Hg or higher (subcritical
ischemia), and limb loss rates are relatively low whether they
undergo revascularization or not.3,4 Information on the presence
of neuropathy and other microvascular complications, as well as
the actual ankle-brachial index, are needed to adequately interpret
the results reported by Conrad et al.
Furthermore, multilevel treatment was necessary in 74% of their
patients. Dilatation of inflow lesions was performed in 40% to 88% of
the patients in infrapopliteal angioplasty studies. Experience with
combined multisegment occlusive disease indicates that treatment of
themore proximal lesion alonewas appropriate in40% to75%of the
patients to relieve CLI.5 The concurrent angioplasty of inflow lesions
may explain the observed high gap between infrapopliteal lesion
patency and limb salvage rates. What were the proximal lesions (ie,
TransAtlantic InterSociety Consensus classification and level), what
procedures were performed for these more proximal lesions (angio-
plasty or bypass surgery), and what were the patency rates of these
procedures in the Conrad et al study? This information is needed to
understand their success in treating these patients.
Finally, indicating angioplasty as the initial therapy in patients
with CLI needs some caution after the results of the Bypass Versus
Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.6 Ap-
proximately 75% of the BASIL cohort survived 2 years, and an
angioplasty-first strategy in these patients did not fare as well as a
bypass surgery-first strategy.
Improvements in endovascular therapy allow an increasing
subset of patients to be treated with angioplasty. Angioplasty and
open surgery are, however, complementary, and therapy must be
individualized. More information is needed from Conrad et al to
fully appreciate their study.
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We respectfully disagree with Dr Meerwaldt and colleagues’
ssertion that diabetic patients with critical limb ischemia will heal
lcers without revascularization. Although it is true that diabetic
ounds are often more difficult to manage due to factors such as
europathy, infection, and microvascular disease, in the absence of
acrovascular blood flow, these wounds simply do not heal. The
urrent study did not intend to address the nuances of manage-
ent of the diabetic foot and indeed, many of our diabetic patients
ie, those with intact macrovasculature) were not included in this
eries.
In our practice, we attempt to re-establish in-line flow to the
oot in patients with tissue loss, and although improvement of
nflow alone will often relieve rest pain, this approach is usually
nadequate for ulcer healing. The disconnect between the primary
atency and limb salvage in the current series is secondary to a strict
efinition of failure and an aggressive posture toward reinterven-
ion, as was stated in the article.
Although the Bypass Versus Angioplasty in Severe Ischaemia
f the Leg (BASIL) trial has shown excellent results with its
rimary end points of survival and limb salvage, it is not applicable
o the current series. Patients in BASIL were included only if there
as agreement that they could be treated with angioplasty or
ypass. In the current series, many of our patients were not bypass
andidates due to comorbidities or a lack of an autogenous con-
uit. In addition, the difference between the two cohorts is accen-
uated by our 24-month survival of 68% (lower in those with
ritical limb ischemia) compared with a higher rate in the BASIL
eries.
Finally, we agree with Dr Meerwaldt and colleagues’ state-
ent that lower extremity revascularization needs to be tailored to
he individual patient and stand by our results as written.
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